Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vivek Chavda, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, Juti Rani Devi, Ratnali Bania & Vasso Apostolopoulos. (2022) Variant influenza: connecting the missing dots. Expert Review of Anti-infective Therapy 20:12, pages 1567-1585.
Read now
Read now
Margaret Haugh, Viviane Gresset-Bourgeois, Bérengère Macabeo, Anne Woods & Sandrine I. Samson. (2017) A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Expert Review of Vaccines 16:6, pages 545-564.
Read now
Read now
Kriangkrai Chawansuntati, Nuntisa Chotirosniramit, Patcharaphan Sugandhavesa, Linda Aurpibul, Sunida Thetket, Natthapol Kosashunhanan, Taweewat Supindham, Oranitcha Kaewthip, Piyathida Sroysuwan, Thira Sirisanthana, Khuanchai Suparatpinyo & Jiraprapa Wipasa. (2015) Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals. Human Vaccines & Immunotherapeutics 11:9, pages 2253-2265.
Read now
Read now
Nuntisa Chotirosniramit, Patcharaphan Sugandhavesa, Linda Aurpibul, Sunida Thetket, Natthapol Kosashunhanan, Taweewat Supindham, Panuwat Wongkulab, Quanhathai Kaewpoowat, Kanokporn Chaiklang, Oranitcha Kaewthip, Piyathida Sroysuwan, Antika Wongthanee, Hatairat Lerdsamran, Pilaipan Puthavathana & Khuanchai Suparatpinyo. (2012) Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand. Human Vaccines & Immunotherapeutics 8:12, pages 1854-1859.
Read now
Read now
Articles from other publishers (8)
Tetsuo Kase, Megumi Inoue, Saeko Morikawa, Hiroko Kumashiro, Satoshi Hiroi, Keiko Nakata, Kazuya Ito, Motoki Ishibashi, Tomomi Tsuru, Shin Irie, Akiko Maeda, Satoko Ohfuji, Wakaba Fukushima & Yoshio Hirota. (2020) Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263). Vaccine 38:42, pages 6524-6532.
Crossref
Crossref
Leena R. Yeolekar, Milan Ganguly, Parikshit Tyagi, Nilesh B. Ingle, Koert J. Stittelaar, Leon de Waal, Francesco Berlanda Scorza, Kutub Mahmood & Rajeev M. Dhere. (2018) Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains. Vaccine 36:46, pages 6944-6952.
Crossref
Crossref
Dimitrios G. Koutsonanos, E. Stein Esser, Sean R. McMaster, Priya Kalluri, Jeong-Woo Lee, Mark R. Prausnitz, Ioanna Skountzou, Timothy L. Denning, Jacob E. Kohlmeier & Richard W. Compans. (2015) Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts. Vaccine 33:37, pages 4675-4682.
Crossref
Crossref
Qiliang Liu, Chunyi Xue, Jing Zheng, Kang Liu, Yang Wang, Ying Wei, George Dacai Liu & Yongchang Cao. (2015) Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice. Vaccine 33:32, pages 4035-4040.
Crossref
Crossref
Ma Teresa Herrera, Yolanda Gonzalez, Esmeralda Juárez, Fernando Hernández-Sánchez, Claudia Carranza, Carmen Sarabia, Silvia Guzman-Beltran, Ma Eugenia Manjarrez, Marcela Muñoz-Torrico, Lourdes Garcia-Garcia, Eduardo Sada & Martha Torres. (2013) Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees. BMC Infectious Diseases 13:1.
Crossref
Crossref
Nicole Le Corre, Fréderic Thibault, Claire Pouteil Noble, Vincent Meiffrédy, Sameh Daoud, Remi Cahen, Isabelle Charreau, David Bottigioli, Cécile Dollinger, Jean-Pierre Aboulker, Brigitte Autran, Emmanuel Morelon & Benoit Barrou. (2012) Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. Vaccine 30:52, pages 7522-7528.
Crossref
Crossref
Jing Zhang, Alison E. While & Ian J. Norman. (2012) Nurses’ vaccination against pandemic H1N1 influenza and their knowledge and other factors. Vaccine 30:32, pages 4813-4819.
Crossref
Crossref
H. Xie, X. Li, J. Gao, Z. Lin, X. Jing, E. Plant, O. Zoueva, M. C. Eichelberger & Z. Ye. (2011) Revisiting the 1976 "Swine Flu" Vaccine Clinical Trials: Cross-reactive Hemagglutinin and Neuraminidase Antibodies and Their Role in Protection Against the 2009 H1N1 Pandemic Virus in Mice. Clinical Infectious Diseases 53:12, pages 1179-1187.
Crossref
Crossref